SCHEMBL2364732

SCHEMBL2364732

CCC(CCCOc1ccc(CCc2cnc3c(N)nc4cc(C)ccc4c3c2)cc1)C(=O)O

nearest known ligand 0.58

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TLR7 Q9NYK1 20/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2354169 0.91 TLR7 (0.72) TLR7
SCHEMBL2364750 0.87 TLR7 (0.58) TLR7
SCHEMBL1060970 0.86 TLR7 (0.63) TLR7
SCHEMBL1060866 0.86 TLR7 (0.60) TLR7
SCHEMBL1009109 0.85 TLR7 (0.64) TLR7
SCHEMBL1008912 0.85 TLR7 (0.63) TLR7
SCHEMBL1062693 0.84 TLR7 (0.63) TLR7
SCHEMBL1062272 0.84 TLR7 (0.61) TLR7
SCHEMBL1010201 0.83 TLR7 (0.64) TLR7
SCHEMBL1062534 0.83 TLR7 (0.59) TLR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2268618-B1 COMPOUNDS AND COMPOSITIONS AS TLR ACTIVITY MODULATORS NOVARTIS AG (CH) 2015-05-27 EP claimed
EP-2512478-A1 HOMOGENEOUS SUSPENSION OF IMMUNOPOTENTIATING COMPOUNDS AND USES THEREOF Novartis AG (CH) 2012-10-24 EP disclosed
WO-2011084549-A1 HOMOGENEOUS SUSPENSION OF IMMUNOPOTENTIATING COMPOUNDS AND USES THEREOF NOVARTIS AG (CH) 2011-07-14 WO disclosed